Patents Assigned to Abbott Diabetes Care Inc.
  • Patent number: 11125592
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: September 21, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Patent number: 11116898
    Abstract: A system for managing a patient's glucose level includes a glucose sensor to generate and store data signals for measurements of the patient's glucose level made by the glucose sensor; an insulin pump; and sensor electronics operatively coupled to the glucose sensor, the sensor electronics comprising a memory storing one or more predetermined characteristics associated with the sensor electronics; and a computing device in electronic communication with the sensor electronics. The computing device comprises a processor configured to operate the sensor electronics to (i) receive the generated data signals, (ii) obtain the one or more predetermined sensor characteristics from the memory and (iii) execute a closed-loop algorithm to provide insulin delivery instructions to an insulin pump by at least using the data signals and predetermined characteristics.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: September 14, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman
  • Patent number: 11116430
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte, such as blood glucose. An inserter having a retractable introducer is provided for subcutaneously implanting the sensor in a predictable and reliable fashion.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: September 14, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Jeffery V. Funderburk, Duane O. Yamasaki, Brian VanHiel, Stephen J. Flynn, Bradley D. Keleman
  • Patent number: 11122043
    Abstract: Systems, devices, and methods are provided that allow the authentication of devices within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a reader device for communicating with the sensor control device. The analyte monitoring systems can interface with a trusted computer system located at a remote site. Numerous techniques of authentication are disclosed that can enable the detection of counterfeit components, such as a counterfeit sensor control device.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: September 14, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Michael R. Love, Mark Sloan, Glenn Berman, Nathan Crouther, Gil Porat
  • Patent number: 11119090
    Abstract: Methods for data processing and control for a medical communication system are provided, including determining a sensitivity value for each sensor of a batch of in vivo analyte sensors; determining a sensitivity variation for each sensor of the batch; determining a mean sensitivity based on the sensitivity value determined for each sensor of the batch when it is determined that the determined sensitivity variation does not exceed a tolerance threshold level; associating a sensor code with each sensor of the batch of in vivo analyte sensors when the mean sensitivity is within a predetermined sensitivity range, wherein the sensor code associated with each sensor is based on a characteristic of the associated sensor; and storing the sensor code associated with at least one sensor of the batch configured to generate signals corresponding to monitored analyte level in a memory of a data processing device associated with the sensor.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: September 14, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Patent number: 11116431
    Abstract: Provided are methods and apparatus for receiving sensor data from an analyte sensor of a sensor monitoring system, processing the received sensor data with time corresponding calibration data, outputting the processed sensor data, detecting one or more adverse conditions associated with the sensor monitoring system, disabling the output of the sensor data during the adverse condition time period, determining that the one or more detected adverse conditions is no longer present in the sensor monitoring system, retrieving the sensor data during the adverse condition time period, processing the retrieved sensor data during the adverse condition time period, and outputting the processed retrieved sensor data.
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: September 14, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Wesley Scott Harper
  • Patent number: 11122641
    Abstract: A system and method of processing information regarding medical devices in wireless communication with each other is provided in which a controller device has a first wireless communication link with a first medical device, such as an analyte sensor, and a second wireless communication link with a second medical device, such as a delivery device. A processor in the controller device monitors the status of the first and second wireless links and upon noting a degradation of either one, compares the first wireless link status with the second wireless link status and provides guidance for resolving a communication problem based on the comparison. The latency of the communicating medical devices is considered.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: September 14, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Mark K. Sloan
  • Publication number: 20210275065
    Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.
    Type: Application
    Filed: May 24, 2021
    Publication date: September 9, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
  • Publication number: 20210267500
    Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.
    Type: Application
    Filed: May 3, 2021
    Publication date: September 2, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Steven Scott, Christopher J. Bennell, Claire Bhogal, Katie A. Cranfield, Marc B. Taub, Bree M. Winter, Owen D. Reynolds, Jean-Pierre Babka, Dharmendra S. Patel, Christopher A. Thomas, Udo Hoss, Mark S. Yahnke, Tahir S. Kahn
  • Patent number: 11103165
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 31, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Adam Heller
  • Patent number: 11099627
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various combinations of installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: August 24, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Publication number: 20210251530
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes an array two or more discontiguous sensing elements deposited on a substrate surface, where the sensing elements comprise one or more droplets of a sensing element formulation.
    Type: Application
    Filed: April 14, 2021
    Publication date: August 19, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Phu Le, Yi Wang, Frank David Fujimoto, Suyue Qian, Lam Tran
  • Patent number: 11091788
    Abstract: Embodiments of the present disclosure relate to NADP-dependent oxidoreductase compositions, and electrodes, sensors and systems that include the same. Also provided are methods for making the compositions and for detecting and/or measuring analytes with NADP-dependent oxidoreductase compositions.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: August 17, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman
  • Patent number: 11083843
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an adverse condition associated with the monitored physiological condition or the medication administration deviating from a predetermined safety level of the closed loop control operation, and initiating a non-zero pre-programmed medication delivery rate are provided.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: August 10, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Marc Barry Taub, Daniel Milfred Bernstein, Mark Kent Sloan
  • Patent number: 11087868
    Abstract: Methods of analyte monitoring management are provided. The methods include indicating on a user interface a plurality of analyte management procedures available for user-selection, where the plurality of analyte management procedures relate to analyte management parameters. Embodiments include receiving an indication to initiate a first procedure of the plurality of analyte management procedures, where the first procedure is for determining a first analyte management parameter. The methods may further include outputting user-instructions associated with the first procedure; receiving analyte measurement data for the first procedure; estimating the first analyte management parameter based on the analyte measurement data; calculating a degree of certainty for the estimation of the first analyte management parameter; and, initiating an action in response to an event associated with a status of the estimation of the first analyte management parameter or the degree of certainty.
    Type: Grant
    Filed: September 27, 2012
    Date of Patent: August 10, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Erwin S. Budiman
  • Publication number: 20210236028
    Abstract: An analyte sensor and methods and systems related thereto, where at least one or more of a lower portion of a sensor tail substrate, at least one electrode, a sensing element, a membrane, and an optional non-electrochemical functional layer comprise an antimicrobial quality. Asymmetric, double-sided adhesive binders suitable for adhering the analyte sensor to a skin surface comprising a non-woven scrim, a first pressure-sensitive adhesive layer, a second pressure-sensitive adhesive layer. Overbandages comprising a vapor-permeable backing, an aperture to circumferentially surround a sensor housing, a contact adhesive layer, first and second peelable release liners, and a third peelable release liner disposed upon an anchoring adhesive strip of the contact adhesive layer.
    Type: Application
    Filed: May 17, 2019
    Publication date: August 5, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Jonathan D. MCCANLESS, Udo HOSS, Benjamin J. FELDMAN, Frank David FUJIMOTO, Steven T. Mitchell
  • Patent number: 11076785
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: August 19, 2017
    Date of Patent: August 3, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Kenneth J. Doniger
  • Publication number: 20210231639
    Abstract: Methods for data processing and control for a medical communication system are provided, including determining a sensitivity value for each sensor of a batch of in vivo analyte sensors; determining a sensitivity variation for each sensor of the batch; determining a mean sensitivity based on the sensitivity value determined for each sensor of the batch when it is determined that the determined sensitivity variation does not exceed a tolerance threshold level; associating a sensor code with each sensor of the batch of in vivo analyte sensors when the mean sensitivity is within a predetermined sensitivity range, wherein the sensor code associated with each sensor is based on a characteristic of the associated sensor; and storing the sensor code associated with at least one sensor of the batch configured to generate signals corresponding to monitored analyte level in a memory of a data processing device associated with the sensor.
    Type: Application
    Filed: April 12, 2021
    Publication date: July 29, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Publication number: 20210228128
    Abstract: Changes in lactate concentrations in vivo may be indicative of a number of physiological conditions, among which can be emotional stress events. Sensing systems for emotional stress events may comprise a lactate-responsive sensor adapted for detecting lactate in vivo, and a processor communicatively coupled to the lactate-responsive sensor. The processor is adapted to determine a plurality of lactate concentrations measured by the lactate-responsive sensor over a period of time. The processor is further adapted to correlate a lactate concentration spike, a lactate concentration change, and/or a lactate concentration rate of change to an emotional stress event occurring within the period of time. The systems may exclude data received during designated or specified sleeping times, exercise, or after eating in order to determine a genuine emotional stress event.
    Type: Application
    Filed: March 6, 2019
    Publication date: July 29, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Hyun Cho, Meghan Sullivan Thompson
  • Patent number: 11071478
    Abstract: Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor, such as a dermal sensor, for sensing an analyte level in a bodily fluid of a subject. An applicator is positioned against a skin surface and a force is applied to the applicator causing at least a portion of a sharp and an in vivo analyte sensor to be positioned in the body of the subject. In particular, disclosed herein are embodiments of applicators designed to prevent premature sharp withdrawal and/or reduce the likelihood of improper sensor insertion. Also disclosed are embodiments of applicators including sharp modules having an angled sharp which can be configured to create an insertion path for a sensor.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: July 27, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Vivek S. Rao, Louis G. Pace, Hyun Cho, Benjamin Jay Feldman, Yi Wang, Tuan Nguyen